På arendalsuka.no bruker vi informasjonskapsler (cookies). Når du bruker vår nettside godkjenner du dette.
Utskrift fra www.arendalsuka.no
Dette var et arrangement i 2018

The Pharmaceutical Industry Revealed: Who, What, Why, and When?

American Chamber of Commerce in Norway
Torsdag 16/8 2018 13:00 - 15:00
Helse , Næringsliv
Clarion Hotel Tyholmen
sal A

Om arrangementet

International pharmaceutical companies produce most of the medicines used by patients across Norway today. Yet, according to firms Apeland and Norstat, only 5% consider the industry to be trustworthy. Further, only 52% of Norwegian survey respondents report being familiar with the pharmaceutical industry at all. Why is this?

Please join senior representatives of Abbvie, Amgen, Bristol-Myers Squibb, Celgene, GSK, Janssen, MSD, Novartis, Pfizer, Roche and special guests for an engaging, open dialogue on just how these companies operate – both now and in the future.

The meeting will be hosted in English to accommodate our international directors and guests.

Panel I: Putting Patients First?

Are pharmaceutical companies neglecting their responsibility to communicate with the Norwegian public? What governs these companies’ decision-making processes – and who are the people that make them? Are shareholder returns prioritized above patient needs? How truly innovative are these companies?

Panel II: The Future of Medicine

As consumers, product and service innovations increasingly impact our everyday lives. As patients, which we will all inevitably be one day, how can we benefit from rapid healthcare and scientific advancements, increased healthcare system efficiencies and precision treatments? What will healthcare look like in 10 years and beyond? Join us for a journey to the future of medicine!

  • Ms. Hilde Bech, Country Manager, Bristol-Myers Squibb Norway
  • Ms. . Lilly Ann Elvestad, Secretary General, The Norwegian Federation of Organizations of Disabled People (FFO)
  • Dr. Ans Heirman, Managing Director, MSD Norge
  • Ms. Lise Lehrmann, ImPatient Mother & Advocate
  • Ms. Tuva Moflag (Ap), Committee on Health & Care Services, Norwegian Parliament
  • Mr. Sveinung Stensland (H), Committee on Health & Care Services, Norwegian Parliament
  • Dr. Roar Johansen, Medical Oncology Subject Matter Expert, IBM Watson Health
  • Ms. Lena Nymo Helli, General Manager, Abbvie
  • Ms. Rajji Medhwan, General Manager, Roche Norge
  • Mr. Ole Alexander Opdalshei, Deputy Secretary General, Norwegian Cancer Society
  • Mr. Jason Turflinger, Managing Director, AmCham Norway
Katja Dahl Murphy, Member & Government Affairs Consultant, American Chamber of Commerce in Norway, 2241 5010, amcham@amcham.no
Universell utforming
Rullestoltilpasset lokale
Rullestoltilpasset WC